Figure 3 | Scientific Reports

Figure 3

From: Baseline characteristics of myopic choroidal neovascularization in patients above 50 years old and prognostic factors after intravitreal conbercept treatment

Figure 3

A 52-year-old male patient with mCNV. BCVA was 20/80 and CMT was 461um. (A) Subfoveal CNV with SRF and fuzzy border was shown on spectral-domain optical coherence tomography at baseline. (B) One month after 2 injections of Conbercept, subretinal fluid was absorbed and BCVA increased to 20/50. (C) Six month later, the patient suffered recurrence of CNV with increasing SRF and BCVA decreased to 20/80, thus one additional injection of Conbercept was given. (D) At one-year follow-up, CNV reduced with dry macula and vision improvement (BCVA was 20/50).

Back to article page